| Date Filed | Type | Description |
| 08/09/2023 |
4
| Thorell Marella (CFO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 2,004 shares
@ $9.51, valued at
$19.1k
Exercised 6,500 restricted stock units
@ $0 |
|
| 05/10/2023 |
4
| Thorell Marella (CFO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 38,531 shares
@ $0.1255, valued at
$4.8k
|
|
| 05/09/2023 |
4
| Thorell Marella (CFO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 130,000 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Thorell Marella (CFO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 520,000 restricted stock units
@ $0 |
|
| 12/15/2022 |
4
| Thorell Marella (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.|
Txns:
| Disposed of 28,517 shares
@ $0 |
|
| 09/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2022 |
4
| Thorell Marella (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.|
Txns:
| Granted 38,023 shares
@ $0 |
|
| 06/10/2022 |
4
| Thorell Marella (Director) has filed a Form 4 on Vallon Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 options to buy
@ $0.51, valued at
$3.8k
|
|
| 03/23/2022 |
4
| Thorell Marella (Chief Accounting Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Acquired 52,101 shares
@ $0 |
|
| 06/04/2021 |
4
| Thorell Marella (Chief Accounting Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Bought 1,000 shares
@ $20, valued at
$20k
|
|
| 06/01/2021 |
4
| Thorell Marella (Chief Accounting Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Granted 58,956 options to buy
@ $0
Granted 9,487 options to buy
@ $0
Granted 208,474 options to buy
@ $0
Granted 137,500 options to buy
@ $20, valued at
$2.8M
|
|
| 05/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/09/2021 |
3
| Thorell Marella (Director) has filed a Form 3 on Vallon Pharmaceuticals, Inc. |
| 01/26/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |